This study is to investigate a MRI radiomics model based on pre-treatment texture features to explore its application value in predicting the efficacy of recombinant human endostatin(RHES) combined concurrent chemoradiotherapy for nasopharyngeal carcinoma. The results showed that the AUC and the accuracy of radiomics-clinics combine model and radiomics model for response assessment in nasopharyngeal carcinoma(NPC) was higher than clinics model. These suggest that pretreatment MRI based radiomics could predict RHES combined concurrent chemoradiotherapy response in NPC, its accuracy was better than clinics model.
This abstract and the presentation materials are available to members only; a login is required.